Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel

References

• Wang K, Yuen ST, Xu J, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46(6):1–9. doi: 10.1038/ng.2983.
   PubMed Web of Science ®Google Scholar
• Kanwal R, Gupta S. Clin genet. Clin Genet. 2012;81(4):303–311. doi: 10.1111/j.1399-0004.2011.01809.x.
   PubMed Web of Science ®Google Scholar
• Zhou R, Wu Y, Wang W, et al. Circular RNAs (circRNAs) in cancer. Cancer Lett. 2018;425:134–142. doi: 10.1016/j.canlet.2018.03.035.
   PubMed Web of Science ®Google Scholar
• Rhie A, Park WS, Choi MK, et al. Genomic copy number variations characterize the prognosis of both P16-positive and P16-negative oropharyngeal squamous cell carcinoma after curative resection. Medicine (Baltimore). 2015;94(50):e2187. doi: 10.1097/MD.0000000000002187.
   PubMed Web of Science ®Google Scholar
• Dear PH. Copy-number variation: the end of the human genome? Trends Biotechnol. 2009;27(8):448–454. doi: 10.1016/j.tibtech.2009.05.003.
   PubMed Web of Science ®Google Scholar
• Wei R, Zhao M, Zheng C-H, et al. Concordance between somatic copy number loss and down-regulated expression: a pan-cancer study of cancer predisposition genes. Sci Rep. 2016;6:37358. doi: 10.1038/srep37358.
   PubMedGoogle Scholar
• Saghafinia S, Mina M, Riggi N, et al. Pan-cancer landscape of aberrant DNA methylation across human tumors. Cell Rep. 2018;25(4):1066–1080.e8. doi: 10.1016/j.celrep.2018.09.082.
   PubMed Web of Science ®Google Scholar
• Yang X, Gao L, Zhang S. Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. Brief Bioinform. 2017;18(5):761–773.
   PubMed Web of Science ®Google Scholar
• Nguyen L, Martens JWM, Van Hoeck A, et al. Pan-cancer landscape of homologous recombination deficiency. Nat Commun. 2020;11(1):5584. doi: 10.1038/s41467-020-19406-4.
   PubMed Web of Science ®Google Scholar
• Jiang T, Chen X, Su C, et al. Pan-cancer analysis of ARID1A alterations as biomarkers for immunotherapy outcomes. J Cancer. 2020;11(4):776–780. doi: 10.7150/jca.41296.
   PubMed Web of Science ®Google Scholar
• Chen C, Chen H, Zhang Y, et al. TBtools: an integrative toolkit developed for interactive analyses of big biological data. Mol Plant. 2020;13(8):1194–1202. doi: 10.1016/j.molp.2020.06.009.
   PubMed Web of Science ®Google Scholar
• Zhu L, Miao Y, Xi F, et al. Identification of potential biomarkers for pan-cancer diagnosis and prognosis through the integration of large-scale transcriptomic data. Front Pharmacol. 2022;13:870660. doi: 10.3389/fphar.2022.870660.
   PubMed Web of Science ®Google Scholar
• Cheerla N, Gevaert O. MicroRNA based pan-cancer diagnosis and treatment recommendation. BMC Bioinformatics. 2017;18(1):32. doi: 10.1186/s12859-016-1421-y.
   PubMedGoogle Scholar
• Bazzi ZA, Tai IT. CDK10 in gastrointestinal cancers: dual roles as a tumor suppressor and oncogene. Front Oncol. 2021;11:655479. doi: 10.3389/fonc.2021.655479.
   PubMed Web of Science ®Google Scholar
• Weiswald L-B, Hasan MR, Wong JCT, et al. Inactivation of the kinase domain of CDK10 prevents tumor growth in a preclinical model of colorectal cancer, and is accompanied by downregulation of Bcl-2. Mol Cancer Ther. 2017;16(10):2292–2303. doi: 10.1158/1535-7163.MCT-16-0666.
   PubMed Web of Science ®Google Scholar
• Düster R, Ji Y, Pan K-T, et al. Functional characterization of the human Cdk10/Cyclin Q complex. Open Biol. 2022;12(3):210381. doi: 10.1098/rsob.210381.
   PubMed Web of Science ®Google Scholar
• Zhong X-Y, Xu X-X, Yu J-H, et al. Clinical and biological significance of Cdk10 in hepatocellular carcinoma. Gene. 2012;498(1):68–74. doi: 10.1016/j.gene.2012.01.022.
   PubMed Web of Science ®Google Scholar
• Khanal P, Yun HJ, Lim SC, et al. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells. Oncogene. 2012;31(34):3845–3856. doi: 10.1038/onc.2011.548.
   PubMed Web of Science ®Google Scholar
• You Y, Li H, Qin X, et al. Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients – a short report. Cell Oncol (Dordr). 2015;38(6):485–491. doi: 10.1007/s13402-015-0246-4.
   PubMed Web of Science ®Google Scholar
• Yu J-H, Zhong X-Y, Zhang W-G, et al. CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells. Oncol Rep. 2012;27(4):1266–1276. doi: 10.3892/or.2011.1617.
   PubMed Web of Science ®Google Scholar
• Zhao BW, Chen S, Li YF, et al. Low expression of CDK10 correlates with adverse prognosis in gastric carcinoma. J Cancer. 2017;8(15):2907–2914. doi: 10.7150/jca.20142.
   PubMed Web of Science ®Google Scholar
• You Y, Bai F, Ye Z, et al. Downregulated CDK10 expression in gastric cancer: association with tumor progression and poor prognosis. Mol Med Rep. 2018;17(5):6812–6818.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yin X, Ni N. The expression of ARID5B gene in ovarian cancer based on oncomine database and the intervention study of sanguinarine. J Pract Obstet Gynecol. 2019;35(7):539–543.
   Google Scholar
• Yamakawa T, Waer C, Itakura K. At-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells. Prostate. 2018;78(16):1238–1247. doi: 10.1002/pros.23699.
   PubMed Web of Science ®Google Scholar
• Zhang JF, Hou SY, You ZL, et al. Expression and prognostics of ARID family members in breast cancer. Aging (Albany NY). 2021;13(4):5621–5637. doi: 10.18632/aging.202489.
   PubMedGoogle Scholar
• Sun J, Cheng NS. Comprehensive landscape of ARID family members and their association with prognosis and tumor microenvironment in hepatocellular carcinoma. J Immunol Res. 2022;2022:1688460.
   PubMed Web of Science ®Google Scholar
• Lim B, Park JL, Kim HJ, et al. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer. Carcinogenesis. 2014;35(5):1020–1027. doi: 10.1093/carcin/bgt409.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yan C, Wang XF, et al. Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy. Cancer Biol Ther. 2022;23(1):104–111. doi: 10.1080/15384047.2021.2011643.
   PubMed Web of Science ®Google Scholar
• Lehrer S, Rheinstein PH. The ADRB1 (adrenoceptor beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer. Discov Med. 2020;30(161):163–171.
   PubMed Web of Science ®Google Scholar
• Wu S, Luo Z, Yu P-J, et al. Suberoylanilide hydroxamic acid (SAHA) promotes the epithelial mesenchymal transition of triple negative breast cancer cells via HDAC8/FOXA1 signals. Biol Chem. 2016;397(1):75–83. doi: 10.1515/hsz-2015-0215.
   PubMed Web of Science ®Google Scholar